China Science & Technology
SEE OTHER BRANDS

Get your science and technology news from China

ACM Research Reports Third Quarter 2025 Results

FREMONT, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- ACM Research, Inc. (“ACM”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its third quarter ended September 30, 2025.

“I am pleased to report another strong quarter for ACM. We grew revenue by 32%, and continue to innovate with world-class tools across multiple product lines. We believe the market is moving toward ACM as AI and global datacenter investments are demanding new innovative technology requirements for next generation semiconductor equipment,” said Dr. David Wang, President and Chief Executive Officer of ACM. “We are seeing broad interest in our proprietary horizontal plating technology for panel-level packaging, with plans to deliver our first system in the fourth quarter. Our high-temperature SPM platform is setting new benchmarks as our proprietary nozzle design achieves industry-best performance at 19nm particle size and below, with significantly lower maintenance and no need to clean the outer chamber. The first shipment of our KrF Track platform in the third quarter further expands our SAM into critical lithography-adjacent applications.”

Dr. Wang continued, “In September, our principal operating subsidiary, ACM Shanghai, raised approximately $623 million in net proceeds from its second capital raise on the STAR Market. We plan to deploy this capital to further accelerate development of next-generation tools, complete the Lingang mini-line, and expand production capacity to support future global demand. We have narrowed the range of our guidance for 2025 revenue, and we remain committed to achieve our $4 billion long-term revenue target.”

  Three Months Ended September 30,
  GAAP   Non-GAAP(1)
    2025       2024       2025       2024  
  (dollars in thousands, except EPS)
Revenue $ 269,160     $ 203,976     $ 269,160     $ 203,976  
Gross margin   42.0 %     51.4 %     42.1 %     51.6 %
Income from operations $ 28,923     $ 44,184     $ 36,485     $ 56,065  
Net income attributable to ACM Research, Inc. $ 35,889     $ 30,904     $ 24,795     $ 42,372  
Basic EPS $ 0.56     $ 0.49     $ 0.39     $ 0.68  
Diluted EPS $ 0.52     $ 0.45     $ 0.36     $ 0.63  


  Nine Months Ended September 30,
  GAAP   Non-GAAP(1)
    2025       2024       2025       2024  
  (dollars in thousands, except EPS)
Revenue $ 656,879     $ 558,647     $ 656,879     $ 558,647  
Gross margin   45.7 %     50.3 %     45.9 %     50.6 %
Income from operations $ 86,394     $ 107,009     $ 113,543     $ 147,801  
Net income attributable to ACM Research, Inc. $ 86,029     $ 72,547     $ 92,874     $ 114,490  
Basic EPS $ 1.35     $ 1.17     $ 1.45     $ 1.85  
Diluted EPS $ 1.26     $ 1.07     $ 1.36     $ 1.70  
                               

(1)   Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized gain (loss) on short-term investments.

Outlook

ACM has narrowed the range of its revenue guidance range for fiscal year 2025 to $875 million to $925 million, versus the prior range of $850 million to $950 million. This expectation is based on ACM management’s current assessment of the continuing impact from international trade policy, together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other factors.

Operating Highlights and Recent Announcements

  • Shipments. Total shipments in the third quarter of 2025 were $263.1 million, up 0.7% from the third quarter of 2024. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.
  • ACM Shanghai Completed its Private Offering. In September 2025, ACM Shanghai issued 38,601,326 ordinary shares at RMB 116.11 per share, raising net proceeds of RMB 4.4 billion (approximately USD $623 million) after deducting offering-related expenses. As a result of the Private Offering, ACM’s equity interests in ACM Shanghai declined from 81.1% as of June 30, 2025 to 74.6% as of September 30, 2025.
  • During the third quarter of 2025, ACM Shanghai paid a cash dividend for a net total of approximately RMB 264.9 million (approximately USD $36.8 million) to the stockholders of ACM Shanghai, including ACM, which owned 81.1% of the outstanding shares of ACM Shanghai at the time.
  • Delivered Its First High-Throughput Ultra Lith KrF Track System to a Leading Chinese Logic Wafer Fab Customer. ACM announced the launch of its first Ultra Lith KrF track system, designed to support front-end semiconductor manufacturing. The new system expands ACM’s lithography product line and delivers high-throughput performance, advanced thermal control, and real-time process control and monitoring. The first system was shipped to a leading Chinese logic wafer fab customer in September 2025.
  • Unveiled Ultra ECDP Electrochemical Deplating Tool for Compound Semiconductor Gold Etch Processes. ACM announced the launch of its first Ultra ECDP Electrochemical Deplating (“Ultra ECDP”) tool specifically designed for wide bandgap compound semiconductor manufacturing. The Ultra ECDP tool is engineered for electrochemical wafer-level gold (Au) etching performed outside of the wafer pattern area and delivers improved uniformity, smaller undercut and enhanced gold line appearance.

Third Quarter 2025 Financial Summary

Unless otherwise noted, the following figures refer to the third quarter of 2025 and comparisons are with the third quarter of 2024.

  • Revenue was $269.2 million, up 32.0%, reflecting growth from single wafer cleaning, Tahoe and semi-critical cleaning equipment, ECP (front-end and packaging), furnace and other technologies, and advanced packaging (excluding ECP), services & spares.
  • Gross margin was 42.0% versus 51.4%. Non-GAAP gross margin, which excludes stock-based compensation, was 42.1% versus 51.6%. Gross margin was at the low end of ACM’s long-term business model target range of 42% to 48%. ACM expects gross margin to vary from period to period due to a variety of factors, such as product mix, currency impacts, sales volume, inventory provisions and other adjustments.
  • Operating expenses were $84.2 million, an increase of 38.9%. Operating expenses as a percentage of revenue increased to 31.3% from 29.7%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $76.9 million, up 56.3%. Non-GAAP operating expenses as a percentage of revenue increased to 28.6% from 24.1%.
  • Operating income was $28.9 million, compared to $44.2 million. Operating margin was 10.7% compared to 21.7%. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $36.5 million, compared to $56.1 million. Non-GAAP operating margin, which excludes stock-based compensation, was 13.6% compared to 27.5%.
  • Unrealized gain on short-term investments was $18.7 million, compared to an unrealized gain of $0.4 million. Unrealized gain reflects the change in market value of the investments by ACM Shanghai. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.
  • Income tax expense was $2.7 million, compared to $4.0 million.
  • Net income attributable to ACM Research, Inc. was $35.9 million, compared to $30.9 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $24.8 million, compared to $42.4 million.
  • Net income per diluted share attributable to ACM Research, Inc. was $0.52, compared to $0.45. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized gain on short-term investments, was $0.36, compared to $0.63.
  • Cash and cash equivalents, plus restricted cash and short-term and long-term time deposits were $1,098.3 million at September 30, 2025, compared to $483.9 million at June 30, 2025.

Conference Call Details

A conference call to discuss results will be held on Wednesday, November 5, 2025, at 8:00 a.m. Eastern Time (9:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.

Online Registration: https://register-conf.media-server.com/register/BI1b6b3109856a47f8ad0506af886844bf

Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.

A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.

Use of Non-GAAP Financial Measures

ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude the effect of stock-based compensation and unrealized gain (loss) on short-term investments, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”

ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.

Forward-Looking Statements

Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

About ACM Research, Inc.

ACM develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing, vertical furnace processes, Track and PECVD, which are critical to advanced semiconductor device manufacturing and wafer-level packaging. ACM is committed to delivering customized, high- performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield. For more information, visit www.acmrcsh.com.

© ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.

For investor and media inquiries, please contact:

In the United States: The Blueshirt Group
  Steven C. Pelayo, CFA
  (360) 808-5154
  steven@blueshirtgroup.co
   
In China: The Blueshirt Group Asia
  Gary Dvorchak, CFA
  +86 (138) 1079-1480
  gary@blueshirtgroup.co


 
ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets
 
  September 30, 2025   December 31, 2024
  (Unaudited)    
  (In thousands)
Assets      
Current assets:      
Cash and cash equivalents $ 1,058,909     $ 407,445  
Restricted cash   8,430       3,865  
Short-term time deposits   30,922       17,277  
Short-term investment   39,976       19,373  
Accounts receivable, net   476,996       387,045  
Other receivables   50,450       41,859  
Inventories, net   676,409       597,984  
Advances to related parties   927       1,024  
Prepaid expenses and other current assets   15,143       7,507  
Total current assets   2,358,162       1,483,379  
Property, plant and equipment, net   296,714       269,272  
Operating lease right-of-use assets, net   18,026       14,038  
Intangible assets, net   2,706       3,461  
Long-term time deposits         13,275  
Deferred tax assets   26,641       14,781  
Long-term investments   63,556       37,063  
Other long-term assets   4,838       20,452  
Total assets $ 2,770,643     $ 1,855,721  
Liabilities and Equity      
Current liabilities:      
Short-term borrowings $ 45,049     $ 32,814  
Current portion of long-term borrowings   48,637       44,472  
Related parties accounts payable   23,323       16,133  
Accounts payable   180,884       139,294  
Advances from customers   203,506       243,949  
Deferred revenue   15,550       8,537  
Income taxes payable         12,779  
FIN-48 payable   21,768       19,466  
Other payables and accrued expenses   135,032       121,657  
Current portion of operating lease liability   4,120       2,132  
Total current liabilities   677,869       641,233  
Long-term borrowings   193,356       105,525  
Long-term operating lease liability   5,882       3,840  
Other long-term liabilities   8,322       9,217  
Total liabilities   885,429       759,815  
Commitments and contingencies      
Equity:      
Stockholders’ equity:      
Class A Common stock   6       6  
Class B Common stock   1       1  
Additional paid-in capital   1,105,129       677,476  
Retained earnings   346,029       260,000  
Statutory surplus reserve   30,514       30,514  
Accumulated other comprehensive loss   (48,999 )     (63,372 )
Total ACM Research, Inc. stockholders’ equity   1,432,680       904,625  
Non-controlling interests   452,534       191,281  
Total equity   1,885,214       1,095,906  
Total liabilities and equity $ 2,770,643     $ 1,855,721  


 
ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Income
 
  Three Months Ended September 30,   Nine Months Ended September 30,
    2025       2024       2025       2024  
  (Unaudited)
  ( In thousands, except share and per share data)
Revenue $ 269,160     $ 203,976     $ 656,879     $ 558,647  
Cost of revenue   156,011       99,142       356,719       277,908  
Gross profit   113,149       104,834       300,160       280,739  
Operating expenses:              
Sales and marketing   22,311       15,759       60,756       47,067  
Research and development   39,651       27,837       100,971       77,723  
General and administrative   22,264       17,054       52,039       48,940  
Total operating expenses   84,226       60,650       213,766       173,730  
Income from operations   28,923       44,184       86,394       107,009  
Interest income   3,100       2,967       10,452       7,122  
Interest expense   (1,851 )     (1,208 )     (5,166 )     (2,923 )
Realized gain on short-term investments   -       171       54       444  
Unrealized gain (loss) on short-term investments   18,656       413       20,304       (1,151 )
Other expense, net   (3,411 )     (5,164 )     (4,019 )     (727 )
Income from equity method investments   3,670       1,316       6,395       101  
Income before income taxes   49,087       42,679       114,414       109,875  
Income tax expense   (2,689 )     (4,007 )     (6,733 )     (17,712 )
Net income   46,398       38,672       107,681       92,163  
Less: Net income attributable to non-controlling interests   10,509       7,768       21,652       19,616  
Net income attributable to ACM Research, Inc. $ 35,889     $ 30,904     $ 86,029     $ 72,547  
Comprehensive income (loss):              
Net income $ 46,398     $ 38,672     $ 107,681     $ 92,163  
Foreign currency translation adjustment, net of tax of nil   9,899       17,089       15,554       10,376  
Unrealized gain on available-for-sale investments, net of tax   2,391       -       2,391       -  
Comprehensive Income   58,688       55,761       125,626       102,539  
Less: Comprehensive income attributable to non-controlling interests   13,017       10,842       25,224       21,458  
Comprehensive income attributable to ACM Research, Inc. $ 45,671     $ 44,919     $ 100,402     $ 81,081  
               
Net income attributable to ACM Research, Inc. per common share:              
Basic $ 0.56     $ 0.49     $ 1.35     $ 1.17  
Diluted $ 0.52     $ 0.45     $ 1.26     $ 1.07  
               
Weighted average common shares outstanding used in computing per share amounts:              
Basic   64,381,296       62,500,903       63,876,709       62,017,257  
Diluted   68,414,313       66,671,526       67,551,302       66,512,143  


   
ACM RESEARCH, INC.
Total Revenue by Product Category
 
   
  Three Months Ended
September 30,

  Nine Months Ended
September 30,

    2025       2024       2025       2024  
  (Unaudited)  
  ($ in thousands)  
Single wafer cleaning, Tahoe and semi-critical cleaning equipment $ 181,570     $ 160,985     $ 466,100     $ 423,676  
ECP (front-end and packaging), furnace and other technologies   59,853       34,600       135,499       99,362  
Advanced packaging (excluding ECP), services & spares   27,737       8,391       55,280       35,609  
Total Revenue By Product Category $ 269,160     $ 203,976     $ 656,879     $ 558,647  


ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures

As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain (loss) on short-term investments. The following tables reconcile gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:

  Three Months Ended September 30,
    2025       2024  
  Actual
(GAAP)
  SBC   Other non-
operating adjustments
  Adjusted
(Non-GAAP)
  Actual
(GAAP)
  SBC   Other non-
operating adjustments
  Adjusted
(Non-GAAP)
  (In thousands)
Revenue $ 269,160     $ -     $ -   $ 269,160     $ 203,976     $ -     $ -   $ 203,976  
Cost of revenue   (156,011 )     (253 )     -     (155,758 )     (99,142 )     (447 )     -     (98,695 )
Gross profit   113,149       (253 )     -     113,402       104,834       (447 )     -     105,281  
Gross margin   42.0 %     0.1 %     -     42.1 %     51.4 %     0.2 %     -     51.6 %
Operating expenses:                              
Sales and marketing   (22,311 )     (1,601 )     -     (20,710 )     (15,759 )     (2,594 )     -     (13,165 )
Research and development   (39,651 )     (1,915 )     -     (37,736 )     (27,837 )     (3,373 )     -     (24,464 )
General and administrative   (22,264 )     (3,793 )     -     (18,471 )     (17,054 )     (5,467 )     -     (11,587 )
Total operating expenses   (84,226 )     (7,309 )     -     (76,917 )     (60,650 )     (11,434 )     -     (49,216 )
Income (loss) from operations   28,923       (7,562 )     -     36,485       44,184       (11,881 )     -     56,065  
Unrealized gain on short-term investments   18,656       -       18,656     -       413       -       413     -  
Net income (loss) attributable to ACM Research, Inc. $ 35,889     $ (7,562 )   $ 18,656   $ 24,795     $ 30,904     $ (11,881 )   $ 413   $ 42,372  
Basic EPS $ 0.56             $ 0.39     $ 0.49             $ 0.68  
Diluted EPS $ 0.52             $ 0.36     $ 0.45             $ 0.63  


  Nine Months Ended September 30,
    2025       2024  
  Actual
(GAAP)
  SBC   Other non-
operating adjustments
  Adjusted
(Non-GAAP)
  Actual
(GAAP)
  SBC   Other non-
operating adjustments
  Adjusted
(Non-GAAP)
  (In thousands)
Revenue $ 656,879     $ -     $ -   $ 656,879     $ 558,647     $ -     $ -     $ 558,647  
Cost of revenue   (356,719 )     (1,138 )     -     (355,581 )     (277,908 )     (2,020 )     -       (275,888 )
Gross profit   300,160       (1,138 )     -     301,298       280,739       (2,020 )     -       282,759  
Gross margin   45.7 %     0.2 %     -     45.9 %     50.3 %     0.4 %     -       50.6 %
Operating expenses:                              
Sales and marketing   (60,756 )     (5,854 )     -     (54,902 )     (47,067 )     (8,645 )     -       (38,422 )
Research and development   (100,971 )     (7,270 )     -     (93,701 )     (77,723 )     (12,082 )     -       (65,641 )
General and administrative   (52,039 )     (12,887 )     -     (39,152 )     (48,940 )     (18,045 )     -       (30,895 )
Total operating expenses   (213,766 )     (26,011 )     -     (187,755 )     (173,730 )     (38,772 )     -       (134,958 )
Income (loss) from operations   86,394       (27,149 )     -     113,543       107,009       (40,792 )     -       147,801  
Unrealized gain (loss)   on short-term investments   20,304       -       20,304     -       (1,151 )     -       (1,151 )     -  
Net income (loss) attributable to ACM Research, Inc. $ 86,029     $ (27,149 )   $ 20,304   $ 92,874     $ 72,547     $ (40,792 )   $ (1,151 )   $ 114,490  
Basic EPS $ 1.35             $ 1.45     $ 1.17             $ 1.85  
Diluted EPS $ 1.26             $ 1.36     $ 1.07             $ 1.70  



Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions